A team of scientists from the Institute of Bioorganic Chemistry RAS, Xenetic Biosciences Inc., OJSC Pharmsynthez and Center of multiple sclerosis and AID of St. Petersburg City Clinical Hospital №31 has created a new form of the vaccine used for the treatment of one of the most severe neurodegenerative autoimmune diseases. The drug has successfully passed pre-clinical trials and two clinical stages. If the results of the third stage of the clinical trials would be positive, the dug shall officially be passed into circulation to be used for the treatment of patients with multiple sclerosis.
- Nobel Laureate in Chemistry visited Russia with lectures
Arieh Warshel, laureate of the Nobel Prize in Chemistry 2013 for "the development of multiscale models for complex chemical systems", had made his first visit in Russia to take part in the Forum unifying the 5th Physiological Congress of CIS and 5th Congress of the Russian Biochemical Society (Dagomys, Sochi, October 4-9, 2016). Professor Warshel had gone by invitation of corresponding member of the RAS, deputy sci-director of the IBCh RAS Alexander Gabibov.
- Scientists have studied the role of sialic acid in cancer development
A group of researchers from the Institute of Bioorganic Chemistry of the Russian Academy of Sciences and Queen’s University (Canada), in conjunction with the Institute of Macromolecular Compounds of the Russian Academy of Sciences, has studied the role of sialic acid in cancer development. The results of their research showed that cancer cells can be manipulated by properly adjusting the acid’s levels, and this can possibly halt the spread of metastases. Their findings were published in the Oncotarget magazine.
- Computer simulates body reaction to heat
For the first time, scientists at the M.M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences have successfully used computer generated simulations to study the TRPV1-Receptor temperature activation phenomenon for higher organisms. Up to this point, it was impossible to achieve such results in silico experiments due to imperfections in the computer simulation models. The results of the experiment were published in the Scientific Reports journal.
- Seminar: "Solving the mechanism of fungal bioluminescence"
IX.8 (This event is over)
8th of September (Thursday) 16:00, Dr Cassius Stevani will deliver a report on the mechanism of fungal bioluminescence: "Solving the mechanism of fungal bioluminescence". Room 34/508
- International Meetig in the Laboratory of Molecular Biophysics
XII.18.15 (This event is over)
- 21.05.15, 12:00, Prof. Miguel Lopez-Botet: “Role of the CD94/NKG2C C-type lectin receptor in the human NK-cell mediated response to cytomegalovirus”
V.20–21.15 (This event is over)